Evolution Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Evolution Wealth Advisors's LLY Position: Q1 2026 in Review
Evolution Wealth Advisors reduced its Eli Lilly (LLY) stake by 24% in Q1 2026, selling an estimated $73K and leaving 229 shares worth $211K. The position accounts for 0.02% of the portfolio, ranked #162.
Evolution Wealth Advisors first reported a position in LLY in Q2 2019 and has held it in 19 quarters since. The position peaked at $323K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Evolution Wealth Advisors held 229 shares of Eli Lilly worth $211K as of Q1 2026.
- Evolution Wealth Advisors sold 72 Eli Lilly shares in Q1 2026, an estimated $73K.
- Eli Lilly made up 0.02% of Evolution Wealth Advisors's portfolio in Q1 2026, its #162 holding.
- Evolution Wealth Advisors first reported a position in Eli Lilly in Q2 2019 and has held it in 19 quarters since.
- Evolution Wealth Advisors's Eli Lilly position peaked at $323K in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Evolution Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.